Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3% hypertonic saline in moderate acute respiratory distress syndrome
PACTR202610729978592Completed
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of hypertonic saline and Normal Saline-Benha University in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: PaO2/FiO2 ratio at 72 hours. Started Oct 2025; status: completed.
02
Drugs
hypertonic salineNormal Saline-Benha University
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on PACTR202610729978592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202610729978592.